Application of Mendelian Randomization in Cardiovascular Disease: Bibliometric Analysis and Visualization from 2003 to 2024

2.

GBD 2019 Diseases and Injuries Collaborators

.

Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019

.

Lancet

.

2020

;

396

(

10258

):

1204

–

22

.

3.

Lx

L

,

Z

X

,

L

G

,

Yl

S

,

Y

L

,

MM

Z

, et al.

Bibliometrics and visualization analysis of Mendelian randomization research in the field of ischemic stroke

.

Chin J Stroke

.

2023

;

18

(

03

):

273

–

80

.

4.

McGue

M

,

Osler

M

,

Christensen

K

.

Causal inference and observational research: the utility of twins

.

Perspect Psychol Sci

.

2010

;

5

(

5

):

546

–

56

.

5.

Emdin

CA

,

Khera

AV

,

Kathiresan

S

.

Mendelian randomization

.

Jama

.

2017

;

318

(

19

):

1925

–

6

.

6.

Smith

GD

,

Ebrahim

S

.

Mendelian randomization: prospects, potentials, and limitations

.

Int J Epidemiol

.

2004

;

33

(

1

):

30

–

42

.

7.

Evangelou

E

,

Warren

HR

,

Mosen-Ansorena

D

,

Mifsud

B

,

Pazoki

R

,

Gao

H

, et al.

Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits

.

Nat Genet

.

2018

;

50

(

10

):

1412

–

25

.

8.

van der Harst

P

,

Verweij

N

.

Identification of 64 novel genetic loci provides an expanded view on the genetic architecture of coronary artery disease

.

Circ Res

.

2018

;

122

(

3

):

433

–

43

.

9.

Yengo

L

,

Sidorenko

J

,

Kemper

KE

,

Zheng

Z

,

Wood

AR

,

Weedon

MN

, et al.

Meta-analysis of genome-wide association studies for height and body mass index in ∼700000 individuals of European ancestry

.

Hum Mol Genet

.

2018

;

27

(

20

):

3641

–

9

.

10.

Chen

J

,

Spracklen

CN

,

Marenne

G

,

Varshney

A

,

Corbin

LJ

,

Luan

J

, et al.

The trans-ancestral genomic architecture of glycemic traits

.

Nat Genet

.

2021

;

53

(

6

):

840

–

60

.

11.

Graham

SE

,

Clarke

SL

,

Wu

KH

,

Kanoni

S

,

Zajac

GJM

,

Ramdas

S

, et al.

The power of genetic diversity in genome-wide association studies of lipids

.

Nature

.

2021

;

600

(

7890

):

675

–

9

.

12.

Rasooly

D

,

Peloso

GM

,

Pereira

AC

,

Dashti

H

,

Giambartolomei

C

,

Wheeler

E

, et al.

Genome-wide association analysis and Mendelian randomization proteomics identify drug targets for heart failure

.

Nat Commun

.

2023

;

14

(

1

):

3826

.

13.

Smith

GD

,

Ebrahim

S

.

Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease

.

Int J Epidemiol

.

2003

;

32

(

1

):

1

–

22

.

14.

Ference

BA

,

Ginsberg

HN

,

Graham

I

,

Ray

KK

,

Packard

CJ

,

Bruckert

E

, et al.

Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel

.

Eur Heart J

.

2017

;

38

(

32

):

2459

–

72

.

15.

Holmes

MV

,

Asselbergs

FW

,

Palmer

TM

,

Drenos

F

,

Lanktree

MB

,

Nelson

CP

, et al.

Mendelian randomization of blood lipids for coronary heart disease

.

Eur Heart J

.

2015

;

36

(

9

):

539

–

50

.

16.

Burgess

S

,

Harshfield

E

.

Mendelian randomization to assess causal effects of blood lipids on coronary heart disease: lessons from the past and applications to the future

.

Curr Opin Endocrinol Diabetes Obes

.

2016

;

23

(

2

):

124

–

30

.

17.

Richmond

RC

,

Sharp

GC

,

Ward

ME

,

Fraser

A

,

Lyttleton

O

,

McArdle

WL

, et al.

DNA methylation and BMI: investigating identified methylation sites at HIF3A in a causal framework

.

Diabetes

.

2016

;

65

(

5

):

1231

–

44

.

18.

Yarmolinsky

J

,

Relton

CL

,

Lophatananon

A

,

Muir

K

,

Menon

U

,

Gentry-Maharaj

A

, et al.

Appraising the role of previously reported risk factors in epithelial ovarian cancer risk: a Mendelian randomization analysis

.

PLoS Med

.

2019

;

16

(

8

):

e1002893

.

19.

Zhong

D

,

Gan

Z

,

Zheng

M

,

Li

L

,

Cheng

H

,

Luo

H

, et al.

Knowledge mapping of nano drug delivery systems across blood: brain barrier from 1996 to 2022: a bibliometric analysis

.

Heliyon

.

2023

;

9

(

5

):

e15828

.

20.

Blount

BC

,

Valentin-Blasini

L

.

Analysis of perchlorate, thiocyanate, nitrate and iodide in human amniotic fluid using ion chromatography and electrospray tandem mass spectrometry

.

Anal Chim Acta

.

2006

;

567

(

1

):

87

–

93

.

21.

de Winter

JCF

,

Zadpoor

AA

,

Dodou

D

.

The expansion of google scholar versus web of science: a longitudinal study

.

Scientometrics

.

2014

;

98

(

2

):

1547

–

65

.

22.

Jiang

S

,

Liu

Y

,

Zheng

H

,

Zhang

L

,

Zhao

H

,

Sang

X

, et al.

Evolutionary patterns and research frontiers in neoadjuvant immunotherapy: a bibliometric analysis

.

Int J Surg

.

2023

;

109

(

9

):

2774

–

83

.

23.

Tanentzap

AJ

,

Smith

BR

.

Unintentional rewilding: lessons for trophic rewilding from other forms of species introductions

.

Philos Trans R Soc Lond B Biol Sci

.

2018

;

373

(

1761

):

20170445

.

24.

Pilkington

A

.

Bibexcel-quick start guide to bibliometrics and citation analysis

.

2018

.

25.

R Core Team

.

R: A language and environment for statistical computing

.

Vienna, Austria

:

R Foundation for Statistical Computing

;

2005

.

26.

van Eck

NJ

,

Waltman

L

.

Software survey: VOSviewer, a computer program for bibliometric mapping

.

Scientometrics

.

2010

;

84

(

2

):

523

–

38

.

27.

Synnestvedt

MB

,

Chen

C

,

Holmes

JH

.

CiteSpace II: visualization and knowledge discovery in bibliographic databases

.

AMIA Annu Symp Proc

.

2005

;

2005

:

724

–

8

.

28.

Eck

NJV

,

Waltman

L

.

Visualizing bibliometric networks

.

Springer International Publishing

;

2014

.

29.

van Eck

NJ

,

Waltman

L

.

Citation-based clustering of publications using CitNetExplorer and VOSviewer

.

Scientometrics

.

2017

;

111

(

2

):

1053

–

70

.

30.

Lee

PC

,

Su

HN

.

Investigating the structure of regional innovation system research through keyword co-occurrence and social network analysis

.

Innovation

.

2010

;

12

(

1

):

26

–

40

.

31.

Bordons

M

,

Aparicio

J

,

González-Albo

B

,

Díaz-Faes

AA

.

The relationship between the research performance of scientists and their position in co-authorship networks in three fields

.

J Informetrics

.

2015

;

9

(

1

):

135

–

44

.

32.

Ebrahim

S

,

Davey Smith

G

.

Mendelian randomization: can genetic epidemiology help redress the failures of observational epidemiology

.

Hum Genet

.

2008

;

123

(

1

):

15

–

33

.

33.

Verbanck

M

,

Chen

CY

,

Neale

B

,

Do

R

.

Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases

.

Nat Genet

.

2018

;

50

(

5

):

693

–

8

.

34.

Nikpay

M

,

Goel

A

,

Won

HH

,

Hall

LM

,

Willenborg

C

,

Kanoni

S

, et al.

A comprehensive 1,000 Genomes-based genome-wide association meta-analysis of coronary artery disease

.

Nat Genet

.

2015

;

47

(

10

):

1121

–

30

.

35.

Bowden

J

,

Davey Smith

G

,

Haycock

PC

,

Burgess

S

.

Consistent estimation in mendelian randomization with some invalid instruments using a weighted median estimator

.

Genet Epidemiol

.

2016

;

40

(

4

):

304

–

14

.

36.

Gray

R

,

Wheatley

K

.

How to avoid bias when comparing bone marrow transplantation with chemotherapy

.

Bone Marrow Transplant

.

1991

;

7

(

Suppl 3

):

9

–

12

.

37.

Keating

S

,

de Witte

T

,

Suciu

S

,

Willemze

R

,

Hayat

M

,

Labar

B

, et al.

The influence of HLA-matched sibling donor availability on treatment outcome for patients with AML: an analysis of the AML 8A study of the EORTC leukaemia cooperative group and GIMEMA. European organization for research and treatment of cancer. Gruppo italiano malattie ematologiche maligne dell'Adulto

.

Br J Haematol

.

1998

;

102

(

5

):

1344

–

53

.

38.

Youngman

LD

,

Keavney

BD

,

Palmer

A

,

Parish

S

,

Collins

R

.

Plasma fibrinogen and fibrinogen genotypes in 4685 cases of myocardial infarction and in 6002 controls: test of causality by “Mendelian randomisation”

.

Circulation

.

2000

;

102

(

18

):

31

–

2

.

39.

Clayton

D

,

McKeigue

PM

.

Epidemiological methods for studying genes and environmental factors in complex diseases

.

Lancet

.

2001

;

358

(

9290

):

1356

–

60

.

40.

Lauridsen

BK

,

Stender

S

,

Kristensen

TS

,

Kofoed

KF

,

Køber

L

,

Nordestgaard

BG

, et al.

Liver fat content, non-alcoholic fatty liver disease, and ischaemic heart disease: mendelian randomization and meta-analysis of 279 013 individuals

.

Eur Heart J

.

2018

;

39

(

5

):

385

–

93

.

41.

Bowden

J

,

Holmes

MV

.

Meta-analysis and Mendelian randomization: a review

.

Res Synth Methods

.

2019

;

10

(

4

):

486

–

96

.

42.

Benn

M

,

Nordestgaard

BG

.

From genome-wide association studies to Mendelian randomization: novel opportunities for understanding cardiovascular disease causality, pathogenesis, prevention, and treatment

.

Cardiovasc Res

.

2018

;

114

(

9

):

1192

–

208

.

43.

Rosoff

DB

,

Davey Smith

G

,

Mehta

N

,

Clarke

TK

,

Lohoff

FW

.

Evaluating the relationship between alcohol consumption, tobacco use, and cardiovascular disease: a multivariable Mendelian randomization study

.

PLoS Med

.

2020

;

17

(

12

):

e1003410

.

44.

Gul

A

,

Zager

P

.

Does altered uric acid metabolism contribute to diabetic kidney disease pathophysiology

.

Curr Diab Rep

.

2018

;

18

(

4

):

18

.

45.

Hsu

CY

,

Yang

W

,

Parikh

RV

,

Anderson

AH

,

Chen

TK

,

Cohen

DL

, et al.

Race, genetic ancestry, and estimating kidney function in CKD

.

N Engl J Med

.

2021

;

385

(

19

):

1750

–

60

.

46.

Sędzikowska

A

,

Szablewski

L

.

Insulin and insulin resistance in alzheimer's disease

.

Int J Mol Sci

.

2021

;

22

(

18

):

9987

.

47.

Tahmi

M

,

Palta

P

,

Luchsinger

JA

.

Metabolic syndrome and cognitive function

.

Curr Cardiol Rep

.

2021

;

23

(

12

):

180

.

48.

Takeishi

J

,

Tatewaki

Y

,

Nakase

T

,

Takano

Y

,

Tomita

N

,

Yamamoto

S

, et al.

Alzheimer's disease and type 2 diabetes mellitus: the use of MCT oil and a ketogenic diet

.

Int J Mol Sci

.

2021

;

22

(

22

):

12310

.

49.

Saklayen

MG

.

The global epidemic of the metabolic syndrome

.

Curr Hypertens Rep

.

2018

;

20

(

2

):

12

.

50.

Sanderson

E

,

Glymour

MM

,

Holmes

MV

,

Kang

H

,

Morrison

J

,

Munafò

MR

, et al.

Mendelian randomization

.

Nat Rev Methods Primers

.

2022

;

2

:

6

.

51.

Chong

M

,

Sjaarda

J

,

Pigeyre

M

,

Mohammadi-Shemirani

P

,

Lali

R

,

Shoamanesh

A

, et al.

Novel drug targets for ischemic stroke identified through mendelian randomization analysis of the blood proteome

.

Circulation

.

2019

;

140

(

10

):

819

–

30

.

52.

Batra

G

,

Ghukasyan Lakic

T

,

Lindbäck

J

,

Held

C

,

White

HD

,

Stewart

RAH

, et al.

Interleukin 6 and cardiovascular outcomes in patients with chronic kidney disease and chronic coronary syndrome

.

JAMA Cardiol

.

2021

;

6

(

12

):

1440

–

5

.

53.

Tzoulaki

I

,

Elliott

P

,

Kontis

V

,

Ezzati

M

.

Worldwide exposures to cardiovascular risk factors and associated health effects: current knowledge and data gaps

.

Circulation

.

2016

;

133

(

23

):

2314

–

33

.

54.

Fewell

Z

,

Davey Smith

G

,

Sterne

JA

.

The impact of residual and unmeasured confounding in epidemiologic studies: a simulation study

.

Am J Epidemiol

.

2007

;

166

(

6

):

646

–

55

.

55.

Smith

GD

,

Lawlor

DA

,

Harbord

R

,

Timpson

N

,

Day

I

,

Ebrahim

S

.

Clustered environments and randomized genes: a fundamental distinction between conventional and genetic epidemiology

.

PLoS Med

.

2007

;

4

(

12

):

e352

.

56.

Yuan

S

,

Tang

B

,

Zheng

J

,

Larsson

SC

.

Circulating lipoprotein lipids, apolipoproteins and ischemic stroke

.

Ann Neurol

.

2020

;

88

(

6

):

1229

–

36

.

57.

Gill

D

,

Georgakis

MK

,

Zuber

V

,

Karhunen

V

,

Burgess

S

,

Malik

R

, et al.

Genetically predicted midlife blood pressure and coronary artery disease risk: mendelian randomization analysis

.

J Am Heart Assoc

.

2020

;

9

(

14

):

e016773

.

58.

Fordyce

CB

,

Roe

MT

,

Ahmad

T

,

Libby

P

,

Borer

JS

,

Hiatt

WR

, et al.

Cardiovascular drug development: is it dead or just hibernating

.

J Am Coll Cardiol

.

2015

;

65

(

15

):

1567

–

82

.

59.

Harrison

RK

.

Phase II and phase III failures: 2013-2015

.

Nat Rev Drug Discov

.

2016

;

15

(

12

):

817

–

8

.

60.

Wang

Q

,

Würtz

P

,

Auro

K

,

Morin-Papunen

L

,

Kangas

AJ

,

Soininen

P

, et al.

Effects of hormonal contraception on systemic metabolism: cross-sectional and longitudinal evidence

.

Int J Epidemiol

.

2016

;

45

(

5

):

1445

–

57

.

61.

Marmot

M

,

Brunner

E

.

Alcohol and cardiovascular disease: the status of the U shaped curve

.

BMJ

.

1991

;

303

(

6802

):

565

–

8

.

62.

Corrao

G

,

Rubbiati

L

,

Bagnardi

V

,

Zambon

A

,

Poikolainen

K

.

Alcohol and coronary heart disease: a meta-analysis

.

Addiction

.

2000

;

95

(

10

):

1505

–

23

.

63.

Mukamal

KJ

,

Rimm

EB

.

Alcohol’s effects on the risk for coronary heart disease

.

Alcohol Res Health

.

2001

;

25

(

4

):

255

–

61

.

64.

Kloner

RA

,

Rezkalla

SH

.

To drink or not to drink? That is the question

.

Circulation

.

2007

;

116

(

11

):

1306

–

17

.

65.

Keenan

T

,

Zhao

W

,

Rasheed

A

,

Ho

WK

,

Malik

R

,

Felix

JF

, et al.

Causal assessment of serum urate levels in cardiometabolic diseases through a mendelian randomization study

.

J Am Coll Cardiol

.

2016

;

67

(

4

):

407

–

16

.

66.

Yang

F

,

Lu

Y

,

Chen

S

,

Wang

K

,

Hu

T

,

Cui

H

.

Sex-specific effect of serum urate levels on coronary heart disease and myocardial infarction prevention: a Mendelian randomization study

.

Nutr Metab Cardiovasc Dis

.

2022

;

32

(

5

):

1266

–

74

.

67.

Efstathiadou

A

,

Gill

D

,

McGrane

F

,

Quinn

T

,

Dawson

J

.

Genetically determined uric acid and the risk of cardiovascular and neurovascular diseases: a mendelian randomization study of outcomes investigated in randomized trials

.

J Am Heart Assoc

.

2019

;

8

(

17

):

e012738

.

68.

Kleber

ME

,

Delgado

G

,

Grammer

TB

,

Silbernagel

G

,

Huang

J

,

Krämer

BK

, et al.

Uric acid and cardiovascular events: a mendelian randomization study

.

J Am Soc Nephrol

.

2015

;

26

(

11

):

2831

–

8

.

69.

Liao

LZ

,

Li

WD

,

Liu

Y

,

Li

JP

,

Zhuang

XD

,

Liao

XX

.

Exploring the causal pathway from omega-6 levels to coronary heart disease: a network Mendelian randomization study

.

Nutr Metab Cardiovasc Dis

.

2020

;

30

(

2

):

233

–

40

.

70.

Mazidi

M

,

Shekoohi

N

,

Katsiki

N

,

Banach

M

.

Omega-6 fatty acids and the risk of cardiovascular disease: insights from a systematic review and meta-analysis of randomized controlled trials and a Mendelian randomization study

.

Arch Med Sci

.

2022

;

18

(

2

):

466

–

79

.

71.

Soininen

P

,

Kangas

AJ

,

Würtz

P

,

Suna

T

,

Ala-Korpela

M

.

Quantitative serum nuclear magnetic resonance metabolomics in cardiovascular epidemiology and genetics

.

Circ Cardiovasc Genet

.

2015

;

8

(

1

):

192

–

206

.

72.

Ala-Korpela

M

,

Davey Smith

G

.

Metabolic profiling-multitude of technologies with great research potential, but (when) will translation emerge

.

Int J Epidemiol

.

2016

;

45

(

5

):

1311

–

8

.

73.

Mundra

PA

,

Shaw

JE

,

Meikle

PJ

.

Lipidomic analyses in epidemiology

.

Int J Epidemiol

.

2016

;

45

(

5

):

1329

–

38

.

74.

Ganz

P

,

Heidecker

B

,

Hveem

K

,

Jonasson

C

,

Kato

S

,

Segal

MR

, et al.

Development and validation of a protein-based risk score for cardiovascular outcomes among patients with stable coronary heart disease

.

JAMA

.

2016

;

315

(

23

):

2532

–

41

.

75.

Hartwig

FP

,

Davies

NM

,

Hemani

G

,

Davey Smith

G

.

Two-sample Mendelian randomization: avoiding the downsides of a powerful, widely applicable but potentially fallible technique

.

Int J Epidemiol

.

2016

;

45

(

6

):

1717

–

26

.

76.

Khera

AV

,

Kathiresan

S

.

Genetics of coronary artery disease: discovery, biology and clinical translation

.

Nat Rev Genet

.

2017

;

18

(

6

):

331

–

44

.

77.

Zheng

J

,

Erzurumluoglu

AM

,

Elsworth

BL

,

Kemp

JP

,

Howe

L

,

Haycock

PC

, et al.

LD Hub: a centralized database and web interface to perform LD score regression that maximizes the potential of summary level GWAS data for SNP heritability and genetic correlation analysis

.

Bioinformatics

.

2017

;

33

(

2

):

272

–

9

.

78.

Staley

JR

,

Blackshaw

J

,

Kamat

MA

,

Ellis

S

,

Surendran

P

,

Sun

BB

, et al.

PhenoScanner: a database of human genotype-phenotype associations

.

Bioinformatics

.

2016

;

32

(

20

):

3207

–

9

.

79.

Davey Smith

G

,

Paternoster

L

,

Relton

C

.

When will mendelian randomization become relevant for clinical practice and public health

.

JAMA

.

2017

;

317

(

6

):

589

–

91

.